Table of Contents Table of Contents
Previous Page  14 / 24 Next Page
Information
Show Menu
Previous Page 14 / 24 Next Page
Page Background

Page 84

conferenceseries

.com

Volume 6

Journal of Infectious Diseases & Therapy

ISSN: 2332-0877

Infection Prevention 2018

December 06-07, 2018

December 06-07, 2018 | Valencia, Spain

14

th

World Congress on

Infection Prevention and Control

In silico epitope prediction, vaccine studies and identification of inhibitors against secretory proteins

of

Plasmodium falciparum

Rani Soni

Central University of Rajasthan, India

M

alaria is one of annihilating problem caused by Plasmodium infection. Due to non-availability of any effective vaccine

and development of drug resistance against the existing drugs malaria could not be eradicated completely. Therefore

there is an urgent need to search for new alternative drug targets or vaccine candidates. To outcompete this we pored over

secretory proteins of plasmodium which are secreted out from the infected erythrocyte, and which is one of the strategies

that parasite utilize to evade the host immune system. Therefore we hypothesize the involvement of secretory proteins in host

immune modulation or in parasite invasion process. Secretory proteins therefore might serve both as good drug target or

vaccine candidates. Our present study is aimed to predict the 3D structure of secretory proteins of Plasmodium falciparum

and we have also performed In-silico screening of diverse drug like molecules against these proteins. The virtual screening

leads to the retrieval of some of the top compounds which were evaluated for their in-vitro anti-malarial activity against

Plasmodium falciparum 3D7 strain. We have identified four compounds with less than 100 nM IC50. We have also predicted

epitopes present in the proteins through different tools like PROPRED, and PREDEP for T cell epitope and BCPRED for Linear

B cell epitope. Out of all predicted epitopes one antigenic peptide was selected on the basis of antigenicity, surface accessibility,

hydrophilicity, and it is synthesized for in-vitro vaccine studies. Synthetic peptide was used for the immunization of mice and

for the detection of cytokine profiling in immunized mice.

soni.rani31@mail.com

J Infect Dis Ther 2018, Volume 6

DOI: 10.4172/2332-0877-C6-054